Delivery Order SPE2DR25D2014-SPE2DR26FZ84A
Award Date 12/1/25
Potential Completion Date 12/2/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $28,295.68. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL). The contract, valued at $7,888.63, is structured as a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. Performance will be completed at the vendor's Conshohocken facility by the ultimate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $1,554.80 delivery order by the Defense Logistics Agency on April 25, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL). The contract utilizes firm fixed pricing with an ultimate completion date of April 28, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a contract ceiling value of $10,361.60. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive bidding with no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL) with a ceiling value of $14,093.39. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The delivery will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on May 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication. The contract, valued at $1,566.65 with a firm fixed-price structure, is scheduled for completion by June 2, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, with a ceiling value of $15,364.62 for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL). The contract employs firm fixed pricing with no set-aside designation, indicating a competitive award. The place of performance is listed as Conshohocken, Pennsylvania, and the ultimate completion date is August...
- AmerisourceBergen Drug Corp was awarded a $6,356.08 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on December 3, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) with an ultimate completion date of December 4, 2025. The award, which was competitively procured without a set-aside designation, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,870.86 and is scheduled for completion by July 31, 2025. The award represents a child contract action under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The delivery order, valued at $33,789.66, represents a firm fixed price contract with an ultimate completion date of September 19, 2025, and was competitively awarded with no set-aside designation. Performance will occur at the vendor's...